Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

259
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
259
T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

238
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
238
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

451
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
451
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

416
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
416

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgA is necessary and sufficient to prevent norovirus infection in mice.

Science translational medicine·2026
Same author

Homeostatic pockets of interferon lambda-stimulated gene production in the intestine are associated with localized exposure to bacterial microbiota.

Gut microbes·2025
Same author

Plasmacytoid dendritic cells in the intestine preferentially produce interferon lambda at homeostasis contributing to tonic localized innate immune responses.

bioRxiv : the preprint server for biology·2025
Same author

Norovirus co-opts NINJ1 for selective protein secretion.

Science advances·2025
Same author

Homeostatic antiviral protection of the neonatal gut epithelium by interferon lambda.

Cell reports·2025
Same author

Interferon regulatory factor 6 (IRF6) determines intestinal epithelial cell development and immunity.

Mucosal immunology·2024

Related Experiment Video

Updated: Oct 15, 2025

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases.

Jonathan W Wallace1, David A Constant1, Timothy J Nice1

  • 1Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, United States.

Frontiers in Immunology
|October 29, 2021
PubMed
Summary

Interferon lambda (IFN-λ) plays a complex role in Inflammatory Bowel Disease (IBD) pathogenesis. Understanding its dual actions in gut healing and cell death offers potential therapeutic strategies for IBD.

Keywords:
Crohn’s disease (CD)inflammatory bowel disease (IBD)interferon lambda (IFN-λ)intestinal epithelial cell (IEC)ulcerative colitis (UC)

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.9K

Related Experiment Videos

Last Updated: Oct 15, 2025

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.9K

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Interferon lambda (IFN-λ) is crucial for antiviral defense at mucosal surfaces, primarily acting on epithelial cells.
  • Inflammatory Bowel Disease (IBD) involves intestinal epithelial cells, with IFN-γ extensively studied, but IFN-λ's role remains unclear.
  • IFN-λ exhibits complex, context-dependent effects in IBD, including promoting gut healing and epithelial cell death.

Purpose of the Study:

  • To review current data on IFN-λ's role in IBD pathogenesis.
  • To identify knowledge gaps in IFN-λ research concerning IBD.
  • To explore the therapeutic potential of modulating IFN-λ signaling in IBD.

Main Methods:

  • Literature review of existing studies on IFN-λ and IBD.
  • Analysis of IFN-λ's diverse functions in epithelial and non-epithelial cells.
  • Discussion of the implications of IFN-λ signaling in IBD pathogenesis.

Main Results:

  • IFN-λ demonstrates both pro-healing effects in the colon and can induce cell death in the small intestine.
  • IFN-λ can modulate non-epithelial cells like neutrophils to control inflammation.
  • IFN-λ generally balances antiviral response with controlled inflammation.

Conclusions:

  • IFN-λ has a multifaceted role in IBD, influencing both disease progression and resolution.
  • Targeting IFN-λ pathways may offer novel therapeutic avenues for IBD management.
  • Further research is needed to fully elucidate IFN-λ's complex functions in IBD.